Response to: Correspondence on 'Current myositis clinical trials and tribulations' by Saygin et al

被引：0
|
作者：
Saygin, Didem [1 ,8 ]
Werth, Victoria [2 ]
Paik, Julie J. [3 ]
Park, Jin Kyun [4 ]
Needham, Merrilee [5 ,6 ]
Lundberg, Ingrid E. [6 ]
Christopher-Stine, Lisa [7 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Dept Med, Div Rheumatol, Pittsburgh, PA USA
[2] Univ Penn, Dept Dermatol, Philadelphia, PA USA
[3] Johns Hopkins Univ, Rheumatol, Baltimore, MD USA
[4] Seoul Natl Univ Hosp, Rheumatol, Seoul, South Korea
[5] IIID Murdoch Univ, Dept Neurol, Perth, WA, Australia
[6] Univ Notre Dame, Perth, WA, Australia
[7] Johns Hopkins Univ, Med Rheumatol, Baltimore, MD USA
[8] Univ Pittsburgh, Med Ctr, Dept Med, Pittburgh, PA 15260 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年
关键词：
Dermatomyositis; Polymyositis; Outcome Assessment; Health Care;
D O I：
10.1136/ard-2024-225762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Response to: 'Correspondence on 'Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis'' by Takanashi et al
    Pinal-Fernandez, Iago
    Casal-Dominguez, Maria
    Milisenda, Jose Cesar
    Mammen, Andrew Lee
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03)
  • [42] Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al
    Duarte-Garcia, Ali
    Graef, Elizabeth R.
    Liew, Jean W.
    Konig, Maximilian F.
    Kim, Alfred Hyoungju
    Sparks, Jeffrey A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (09)
  • [43] Clinical anatomy - Response to Bhatnagar et al.
    Leonard, RJ
    Lozanoff, S
    CLINICAL ANATOMY, 2000, 13 (04) : 303 - 304
  • [44] Response to 'Augmented vs. artificial intelligence for stratification of patients with myositis' by Mahler et al
    Meyer, Alain
    Spielmann, Lionel
    Severac, Francois
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (12)
  • [45] Considerations About Designing and Reporting Randomized Clinical Trials - Response to the Letter to the Editor From Preus et al
    Faveri, Marcelo
    Figueiredo, Luciene Cristina
    Feres, Magda
    JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE, 2015, 15 (02) : 87 - 88
  • [46] In response to Lebwohl et al, "Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials''
    Rieder, Evan A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03)
  • [47] Response to: Correspondence on 'Hypertensive response to exercise in adult patients with repaired aortic coarctation' by Pavsic et al
    Meijs, Timion A.
    Voskuil, Michiel
    HEART, 2022, 108 (16) : 1328 - 1329
  • [48] Zuranolone provides a rapid response without chronic dosing: Response to correspondence by ten Doesschate et al
    Arnaud, Alix
    Bonthapally, Vijayveer
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 301 : 445 - 447
  • [49] Response to: 'Correspondence on 'EULAR recommendations for the management of antiphospholipid syndrome in adults' by Zhou et al
    Tektonidou, Maria G.
    Tincani, Angela
    Ward, Michael M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12)
  • [50] Response to: Correspondence on "Update on the diagnosis and management of systemic lupus erythematosus" by Zhou et al
    Fanouriakis, Antonis
    Tziolos, Nikolaos
    Bertsias, George
    Boumpas, Dimitrios T.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (08)
12345